Transformación tumorigénica por CPI-17 a través de la inhibición de una fosfatasa de merlina
Hongchuan Jin1, Tobias Sperka, Peter Herrlich
1Leibniz Institute of Age Research-Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.
Nature
|August 4, 2006
Resumen
La miosina fosfatasa (MYPT-1-PP1delta) activa el supresor del tumor merlina por desfosforilación. Su inhibidor, CPI-17, promueve el cáncer al interrumpir esta vía de merlín, destacando una nueva cascada supresora de tumores.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Biología celular Biología celular.
- Oncología Oncología.
Sus antecedentes:
- Merlin (gen de la neurofibromatosis tipo 2 NF2) es un supresor de tumores que regula la proliferación celular.
- La activación de Merlin requiere desfosforilación en la serina 518 (S518), pero la fosfatasa responsable era desconocida.
Objetivo del estudio:
- Para identificar la fosfatasa que activa la función supresora del tumor de Merlin.
- Para investigar el papel de esta fosfatasa y su inhibidor en el cáncer.
Principales métodos:
- Análisis de identificación de enzimas. ensayos de identificación de enzimas.
- Ensayos celulares utilizando mutantes de merlín y un inhibidor del CPI-17.
- Análisis de los niveles de CPI-17 en líneas de células tumorales humanas.
Principales resultados:
- La miosina fosfatasa (MYPT-1-PP1delta) fue identificada como la fosfatasa activadora de la merlina.
- El inhibidor delta-específico del MYPT-1-PP1 CPI-17 causa la fosforilación de la merlina, la activación de Ras y la transformación celular.
- La regulación a la baja del IPC-17 revirtió estos efectos oncogénicos, confirmando la merlina como el sustrato clave.
Conclusiones:
- MYPT-1-PP1delta y merlin forman una nueva cascada supresora de tumores.
- Esta cascada puede ser interrumpida por mutaciones NF2 o aumento de los niveles de CPI-17, lo que contribuye a la tumorigénesis.
Videos de Conceptos Relacionados
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...